Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021-2022): a controlled interrupted time series analysis
CONCLUSIONS: The 2021 lockdowns and 2021/2022 Omicron outbreaks in NSW and Victoria had significant impacts on the dispensing, initiation and discontinuation of systemic cancer therapies, however, the overall effects were minimal. The impacts of lockdowns were less significant than the Omicron outbreaks, suggesting COVID-19 infection, health system capacity, and patient and community concerns were important factors for treatment changes.PMID:38369711 | DOI:10.17061/phrp34012402
Source: Cancer Control - Category: Cancer & Oncology Authors: Forrest C Koch Monica Tang Ramesh Walpola Maria Aslam Sallie-Anne Pearson Benjamin Daniels Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | Cancer Therapy | Coronavirus | COVID-19 | Endocrine Therapy | International Medicine & Public Health | Outbreaks | Pandemics | Study | Wales Health